Oral administration of hexanoate, an SCFA/MCFA, increased the concentration of hexanoic acid in the tumor tissue and draining lymph nodes (Figure 1a), and significantly inhibited tumor growth (Figure 1b), in CT26 tumor‐bearing mice. This evidence concerns the gene DDX53 and neoplasm.